BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25120810)

  • 1. C-kit and PDGFRA gene mutations in triple negative breast cancer.
    Zhu Y; Wang Y; Guan B; Rao Q; Wang J; Ma H; Zhang Z; Zhou X
    Int J Clin Exp Pathol; 2014; 7(7):4280-5. PubMed ID: 25120810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
    Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs)].
    He HY; Xiang YN; Li Y; Zhong HH; Wu BQ; Zheng J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):320-4. PubMed ID: 15968329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors (GISTs): role of CD 117 and PDGFRA Golgi-like staining pattern in the recognition of mutational status.
    Jaramillo S; Ríos-Moreno MJ; Hernández A; Amérigo J; Trigo-Sánchez I; González-Cámpora R
    Rev Esp Enferm Dig; 2012 Mar; 104(3):128-33. PubMed ID: 22449154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors.
    Holden JA; Willmore-Payne C; Coppola D; Garrett CR; Layfield LJ
    Am J Clin Pathol; 2007 Aug; 128(2):230-8. PubMed ID: 17638656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
    Bombac A; Zakotnik B; Bucic M; Setrajcic Dragos V; Gazic B; Stegel V; Klancar G; Novakovic S
    Int J Oncol; 2020 Jun; 56(6):1468-1478. PubMed ID: 32236636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and protein expression of KIT and PDGFRA genes in ipsilateral testicular seminomas: an immunohistochemical and molecular genetic study.
    Terada T
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):450-3. PubMed ID: 21403518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
    Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
    Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
    Swick BL; Srikantha R; Messingham KN
    J Cutan Pathol; 2013 Jul; 40(7):623-30. PubMed ID: 23621836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis.
    Kartha RV; Sundram UN
    Mod Pathol; 2008 Feb; 21(2):96-104. PubMed ID: 18084259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations.
    Cao D; Antonescu C; Wong G; Winter J; Maitra A; Adsay NV; Klimstra DS; Hruban RH
    Mod Pathol; 2006 Sep; 19(9):1157-63. PubMed ID: 16778826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of an Italian series of sporadic GISTs.
    Origone P; Gargiulo S; Mastracci L; Ballestrero A; Battistuzzi L; Casella C; Comandini D; Cusano R; Dei Tos AP; Fiocca R; Garuti A; Ghiorzo P; Martinuzzi C; Toffolatti L; ; Bianchi Scarrà G
    Gastric Cancer; 2013 Oct; 16(4):596-601. PubMed ID: 23291969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
    J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
    Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
    Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases.
    Terada T
    Int J Clin Oncol; 2010 Oct; 15(5):453-6. PubMed ID: 20425130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
    Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.
    Rossi S; Gasparotto D; Miceli R; Toffolatti L; Gallina G; Scaramel E; Marzotto A; Boscato E; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Mariani L; Amore P; Gronchi A; Casali PG; Maestro R; Dei Tos AP
    Am J Surg Pathol; 2015 Jul; 39(7):922-30. PubMed ID: 25970686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.